Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease

被引:0
|
作者
Ronglin Wang
Fangfang Lu
Gang Zhu
Dayun Feng
Tiejian Nie
Kai Tao
Shaosong Yang
Jie Lei
Lu Huang
Zixu Mao
Qian Yang
机构
[1] The Fourth Military Medical University,Department of Neurosurgery, Tangdu Hospital
[2] Emory University School of Medicine,Departments of Pharmacology and Neurology
[3] GuangZhou Medical University,Department of Neurology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
MiRNAs, a group of powerful modulator of gene expression, participate in multiple cellular processes under physiological and pathological conditions. Emerging evidence shows that Drosha, which controls the initial step in canonical miRNA biogenesis, is involved in modulating cell survival and death in models of several diseases. However, the role of Drosha in Parkinson’s disease (PD) has not been well established. Here, we show that the level of Drosha decreases in 6-OHDA-induced cellular and animal models of PD. 6-OHDA induced a p38 MAPK-dependent phosphorylation of Drosha. This triggered Drosha degradation. Enhancing the level of Drosha protected the dopaminergic (DA) neurons from 6-OHDA-induced toxicity in both in vitro and in vivo models of PD and alleviated the motor deficits of PD mice. These findings reveal that Drosha plays a critical role in the survival of DA neurons and suggest that stress-induced destabilization of Drosha may be part of the pathological process in PD.
引用
收藏
相关论文
共 50 条
  • [31] Selective inhibition of NF-kB activation prevents the loss of dopaminergic neuron in the mouse model of Parkinson's disease
    Ghosh, A.
    Ray, A.
    Liu, X.
    Pahan, K.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 266 - 266
  • [32] Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease
    Pereira, Carolina Parga Martins
    Francis-Oliveira, Jose
    Singulani, Monique Patricio
    Ferreira, Ana Flavia Fernandes
    Britto, Luiz Roberto G.
    JOURNAL OF NEUROIMMUNOLOGY, 2023, 375
  • [33] Oxidative stress to dopaminergic neurons as models of Parkinson's disease
    Gille, G
    Hung, ST
    Reichmann, H
    Rausch, WD
    STRESS: CURRENT NEUROENDOCRINE AND GENETIC APPROACHES, 2004, 1018 : 533 - 540
  • [34] PUERARIN PROTECTS DOPAMINERGIC NEURONS IN PARKINSON'S DISEASE MODELS
    Zhang, X.
    Xiong, J.
    Liu, S.
    Wang, L.
    Huang, J.
    Liu, L.
    Yang, J.
    Zhang, G.
    Guo, K.
    Zhang, Z.
    Wu, P.
    Wang, D.
    Lin, Z.
    Xiong, N.
    Wang, T.
    NEUROSCIENCE, 2014, 280 : 88 - 98
  • [35] Parkinson's disease: animal models and dopaminergic cell vulnerability
    Blesa, Javier
    Przedborski, Serge
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [36] Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson's disease
    Yao, Ning
    Wu, Yanhong
    Zhou, Yan
    Ju, Lili
    Liu, Yujun
    Ju, Rongkai
    Duan, Deyi
    Xu, Qunyuan
    BRAIN RESEARCH, 2015, 1625 : 255 - 274
  • [37] CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease
    Smith, PD
    O'Hare, MJ
    Park, DS
    TRENDS IN MOLECULAR MEDICINE, 2004, 10 (09) : 445 - 451
  • [38] Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease
    Trinh, Kien
    Moore, Katherine
    Wes, Paul D.
    Muchowski, Paul J.
    Dey, Joyoti
    Andrews, Laurie
    Pallanck, Leo J.
    JOURNAL OF NEUROSCIENCE, 2008, 28 (02): : 465 - 472
  • [39] Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter
    Hartmann, A
    Hunot, S
    Hirsch, EC
    EXPERIMENTAL NEUROLOGY, 2003, 184 (02) : 561 - 564
  • [40] Necdin Prevents Loss of Dopaminergic Neurons in Experimental Parkinson's Disease
    Mochizuki, Hideki
    Yasuda, Toru
    Yoshikawa, Kazuaki
    Mizuno, Yoshikuni
    NEUROTHERAPEUTICS, 2013, 10 (03) : 542 - 542